A Comparison of Renal vs Limb NIRS for Predicting Cardiac Surgery Associated Acute Kidney Injury

NCT ID: NCT06705855

Last Updated: 2025-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-29

Study Completion Date

2026-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute kidney injury (AKI) is a complication of cardiac surgery that can affect outcome. Near Infrared Spectroscopy (NIRS) is a technology that uses light to determine how well oxygenated tissues are. This technology is routinely used in cardiac surgery to measure the oxygen level in the brain by placing a sensor sticker on the forehead. The purpose of the study is to determine whether NIRS sensor stickers placed on the skin over the kidney can predict AKI better than when sensors are placed on the skin over the participant's limbs. This study is being conducted by investigators from the department of anesthesiology at the University of Utah.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute kidney injury (AKI) is a common complication of cardiac surgery occurring in up to 40% of patients.1, 2 This is more than 10 times the rate of other serious post-surgical complications in cardiac surgery such as stroke or deep sternal infection and is even greater than the incidence of prolonged ventilation.3, 4 Severe AKI requiring new onset dialysis after cardiac surgery occurs in 1-6% of cardiac surgery patients.3, 5 AKI increases length of hospital stay from 5 to 11 days and increases hospital costs from $18,463 to $37,674 per patient.6 The severity of AKI is strongly associated with in-hospital mortality with even the mildest forms of AKI having more than double the mortality and the more severe forms having 10-30 times higher mortality rates (depending on the definition of severe AKI and the patient population).6, 7 AKI contributes to 300,000 annual deaths in the U.S. and 2 million deaths globally each year.8, 9 Considering only the most relevant patient populations (major aortic and spinal surgery, relevant cardiovascular procedures, intensive care patients on mechanical ventilation, severe trauma patients), in the US alone more than 3.1 million patients per year are at risk of AKI.10-14 Of those, 30.6%12, 13, 15 will suffer AKI - adding annual hospital costs of $19 billion.6 It is for these reasons that the Society of Thoracic Surgeons lists renal failure as one of the 5 major complications of cardiac surgery.

The pathophysiology of AKI after cardiac surgery is multifactorial but the profound hemodynamic changes that occur in cardiac surgery likely play an important role. The renal medulla has the highest metabolic activity and least oxygen reserve in the kidney and medullary hypoxia is thought to be a major determinant of AKI.16, 17 One major limitation in the effort to reduce the incidence of AKI is the lack of a real-time monitor of renal hypoxia. As there is no current therapy for AKI once the disease has occurred, prevention is the mainstay of treatment and an important step in preventing AKI is its timely recognition. Current diagnostic methods based on serum creatinine, oliguria, or even novel biomarkers, however, take hours to days to become diagnostic. The investigators have no accepted standard for diagnosing kidney hypoxia in real-time before the injury becomes irreversible. Most clinicians base intraoperative hemodynamic goals for the kidney on "educated guesses" of adequate renal perfusion, since the exact cardiac output or mean arterial pressure targets for preventing AKI are unknown. Even the practice of monitoring urine output is uncertain because of its non-specific relationship to kidney function.18-20 Near infrared spectroscopy (NIRS) is a promising technology for monitoring tissue hypoxia because it is noninvasive and has a long history of clinical use as a monitor of cerebral oximetry in both cardiac and vascular surgery. Because NIRS measures a mixture of arterial and venous capillary oxygenation, it is particularly well-suited to monitor the balance between oxygen consumption and delivery. A large body of literature describes the use of NIRS both as a systemic perfusion monitor and a regional monitor of kidney perfusion in neonates and small children.21-26 In adult cardiac surgery patients, two studies using ultrasound guided placement of NIRS sensors over the kidney found that intraoperative regional tissue oxygen desaturations were associated with the subsequent development of AKI.27, 28 A third study found a correlation between NIRS oxygen saturation measurements over the kidney and renal venous oxygen saturation in adult cardiac surgery patients.29 The problem with these studies, however, is that they excluded patients for body mass index (BMI) greater than 30kg/m2 or if the surface of their kidney was greater than 4cm from the skin. According to the Center for Disease Control, the incidence of obesity (BMI greater than 30kg/m2) is over 40% in the United States and obese patients having cardiac surgery are at increased risk for AKI.30, 31 Thus, if NIRS placed over the kidney in adult patients is to be an effective tool in monitoring kidney hypoxia in adults in the United States, then the technology must be effective in all adult patients.

The major limitation to the use of NIRS for renal hypoxia monitoring in adults is the depth of penetration of the signal. Manufacturers guidelines suggest that the maximum depth of penetration of NIRS is 2.5 cm. The actual depth of penetration of NIRS measurements depends on the source-detector separation, the specific algorithm used, and the optical properties of the tissue being measured. When NIRS is modeled experimentally, there is a nonlinear relationship between source-detector separation and depth of penetration such that a source-detector separation of 20 mm resulted in a depth of penetration of 10 mm but a source-detector separation of 40mm resulted in a depth of penetration of 15mm.32 While in very thin adults, the surface of the kidney may be within 2 cm from the skin, the renal medulla (where most AKI is thought to occur) is several centimeters deeper and thus unlikely to be monitored accurately.

The question then arises as to how these adult cardiac surgery studies showed a relationship between NIRS placed over the kidney, AKI outcome, and even renal venous oxygen saturation.27-29 The lab developed a porcine model in which the investigators directly compared kidney medullary oxygen concentration to NIRS measurements placed over the kidney and the thigh during hemorrhagic shock and aortic occlusion.33 The investigators found during extreme hemodynamic changes such as aortic occlusion, there was a moderate correlation between NIRS and invasive kidney tissue oxygen concentration, but this was true irrespective of whether the NIRS sensors were placed over the kidney or over the thigh. The relationship between kidney NIRS and thigh NIRS was stronger than that with kidney oxygen concentration. This was in animals with kidney surface to skin distances of less than 2 cm. Taken together, these data suggest that renal NIRS in adults may be measuring subcutaneous tissue oxygenation but that it is still a global perfusion monitor that may predict poor global perfusion and AKI risk. Indeed, a study in adult cardiac surgery patients showed that NIRS sensors placed over the thigh predicted subsequent AKI with receiver operator characteristic analysis suggesting an optimal cut-off of 67% and an area under the curve of 0.84.34 The purpose of the current study proposal is to directly compare NIRS placed over the kidney to NIRS placed over the arm or the thigh in adult patients having cardiac surgery at risk for AKI. The hypothesis is that limb NIRS and kidney NIRS will both predict AKI and that the ability of NIRS to predict AKI in adult cardiac surgery patients will be independent of BMI and kidney surface to skin distance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

NIRS Cardiac Surgery Associated - Acute Kidney Injury Cardiac Surgery Requiring Cardiopulmonary Bypass AKI - Acute Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult cardiac surgery patients undergoing cardiopulmonary bypass surgery at risk for AKI

We will enroll a convenience sample of adult cardiac surgery patients undergoing procedures that require cardiopulmonary bypass (CPB) and who are at risk for AKI.

NIRS sensor placement

Intervention Type DEVICE

After written informed consent, the patient will be brought to the operating room. Skin tone will be assessed using the Monk scale. Prior to induction of general anesthesia, the right kidney will be located by surface ultrasound, the distance between the renal capsule and the skin will be measured, and a NIRS sensor will be placed on the skin overlaying the kidney. If the patient has had a right nephrectomy, the left kidney will be used. Additional NIRS sensors will then be placed over the patient's ipsilateral biceps and vastus lateralis muscles. The distance from the skin to the muscle tissue will be measured and recorded using ultrasound. NIRS sensors will also be placed on the patient's forehead to measure cerebral oximetry as is current practice at our institution for all cardiac surgeries requiring cardiopulmonary bypass.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NIRS sensor placement

After written informed consent, the patient will be brought to the operating room. Skin tone will be assessed using the Monk scale. Prior to induction of general anesthesia, the right kidney will be located by surface ultrasound, the distance between the renal capsule and the skin will be measured, and a NIRS sensor will be placed on the skin overlaying the kidney. If the patient has had a right nephrectomy, the left kidney will be used. Additional NIRS sensors will then be placed over the patient's ipsilateral biceps and vastus lateralis muscles. The distance from the skin to the muscle tissue will be measured and recorded using ultrasound. NIRS sensors will also be placed on the patient's forehead to measure cerebral oximetry as is current practice at our institution for all cardiac surgeries requiring cardiopulmonary bypass.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* We will enroll a convenience sample of adult cardiac surgery patients undergoing procedures that require cardiopulmonary bypass (CPB) and who are at risk for AKI.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Utah

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Natalie Silverton

Associate Professor of Anesthesiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Natalie Silverton, MD

Role: PRINCIPAL_INVESTIGATOR

University of Utah

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Utah

Salt Lake City, Utah, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Natalie Silverton, MD

Role: CONTACT

801-581-6393

Natalie Bennion, MPH

Role: CONTACT

801-585-7697

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Natalie Silverton, MD

Role: primary

801-581-6393

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00179157

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.